Anand Bhaskar
SEC insider (Form 3/4/5 filer). CIK 0001890784. Chief Accounting Officer at Summit Therapeutics Inc. (SMMT). 8 reported Form 4/5 transactions since Sep 2024; latest on Oct 8, 2026. Located in MIAMI, FL.
Companies Anand Bhaskar has filed insider reports for
- Summit Therapeutics Inc. (SMMT): Officer, Chief Accounting Officer
Anand Bhaskar
CIK: 0001890784
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Summit Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Oct 8, 2026SMMT
Summit Therapeutics Inc.
AwardDirect100K shares- - Jan 8, 2026SMMT
Summit Therapeutics Inc.
AwardDirectStock Option (right to buy)
30K shares- - Oct 21, 2025SMMT
Summit Therapeutics Inc.
AwardDirect26.7K shares at avg. $18.74$500K - Sep 18, 2025SMMT
Summit Therapeutics Inc.
AwardDirectStock Option (right to buy)
50K shares- - Apr 29, 2025SMMT
Summit Therapeutics Inc.
AwardDirectStock Option (right to buy)
600K shares- - Apr 29, 2025SMMT
Summit Therapeutics Inc.
AwardDirectStock Option (right to buy)
75K shares- - Jan 12, 2025SMMT
Summit Therapeutics Inc.
AwardDirectStock Option (right to buy)
75K shares- - Sep 11, 2024SMMT
Summit Therapeutics Inc.
AwardDirect22K shares at avg. $22.70$500K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 8, 2026 | SMMT Summit Therapeutics Inc. | Award | 100,000 | - | $0 | Direct |
| Jan 8, 2026 | SMMT Summit Therapeutics Inc. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| Oct 21, 2025 | SMMT Summit Therapeutics Inc. | Award | 26,680 | $18.74 | $499,983 | Direct |
| Sep 18, 2025 | SMMT Summit Therapeutics Inc. | Award Stock Option (right to buy) | 50,000 | - | - | Direct |
| Apr 29, 2025 | SMMT Summit Therapeutics Inc. | Award Stock Option (right to buy) | 600,000 | - | - | Direct |
| Apr 29, 2025 | SMMT Summit Therapeutics Inc. | Award Stock Option (right to buy) | 75,000 | - | - | Direct |
| Jan 12, 2025 | SMMT Summit Therapeutics Inc. | Award Stock Option (right to buy) | 75,000 | - | - | Direct |
| Sep 11, 2024 | SMMT Summit Therapeutics Inc. | Award | 22,026 | $22.70 | $499,990 | Direct |
1-8 of 8 transactions